Natco Pharma Shares Slump 18.5% Amid Disappointing Q3 Earnings
Natco Pharma’s stock took a severe hit on February 13, plunging 18.5% as investors reacted negatively to the company’s weak Q3 earnings report. The pharmaceutical firm reported a 38% drop in net profit, which stood at ₹132.4 crore for the quarter, compared to ₹212.7 crore in the same period last year. Revenue also declined significantly […]
Natco Pharma Shares Slump 18.5% Amid Disappointing Q3 Earnings Read More »









